Aspen strikes deal with J&J to make COVID-19 vaccine in South Africa
Aspen Pharmacare, has announced that it has reached an agreement with American drugmaker Johnson & Johnson to commercially manufacture its COVID-19 vaccine candidate in South Africa. Aspen, South Africa’s largest pharmaceutical company, will also perform formulation, filling and secondary packaging of the vaccine for the U.S. firm, the company said. Currently, the vaccine candidate is…